# StrataCTX® as a Steroid Sparing Device

> **NCT04087629** · NA · RECRUITING · sponsor: **Columbia University** · enrollment: 70 (estimated)

## Conditions studied

- CTCL

## Interventions

- **DEVICE:** StrataCTX® gel

## Key facts

- **NCT ID:** NCT04087629
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-07
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04087629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04087629, "StrataCTX® as a Steroid Sparing Device". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04087629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*